Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00321_DB01026_nanopub.RAI-3WH5t2zSwCS_DgKW8HXsaPwVy5cCWJnDjtl1y0hV4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00321_DB01026 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00321_DB01026 label "DDI between Amitriptyline and Ketoconazole - Ketoconazole, a moderate CYP2D6 inhibitor, may increase the serum concentration of amitriptyline by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amitriptyline if ketoconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00321_DB01026]" assertion.
- drugbank_resource:DB00321_DB01026 identifier "drugbank_resource:DB00321_DB01026" assertion.
- drugbank_resource:DB00321_DB01026 title "DDI between Amitriptyline and Ketoconazole - Ketoconazole, a moderate CYP2D6 inhibitor, may increase the serum concentration of amitriptyline by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amitriptyline if ketoconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00321 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00321_DB01026 assertion.
- drugbank:DB01026 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00321_DB01026 assertion.